*Strides Pharma Science Ltd.* has acquired 70 percent stake in Switzerland-based Fairmed Healthcare AG for CHF 2.2 million (over Rs 15.50 crore). The company’s step-down subsidiary Strides Pharma Global Pte. Ltd. has acquired a majority stake in Fairmed Healthcare AG which has a portfolio of generic products encompassing prescription and over-the-counter drugs across several therapeutic segments. Under the terms of the agreement, Strides Pharma Global Pte will hold 70 percent of the issued capital of Fairmed. Strides has infused CHF (Swiss franc) 2.2 million into the entity in lieu of the equity stake. The acquisition further strengthens Strides’ footprint in continental Europe. The business will incrementally have access to Strides’ already approved product portfolio for the markets Fairmed operates in.
Feedback
STAR 
Reputation: 13,324 • Sep 12, 2019 3:31 AM
Vote
Comment
Share